Baxter Bosses Sued Over $588M Pump Recall, Plasma Prices

Law360, Wilmington (June 10, 2013, 9:18 PM EDT) -- An investor in medical device giant Baxter International Inc. hit 11 members of the company's board with a derivative suit Monday, claiming they didn't do enough to investigate fraud accusations connected to a $588 million infusion pump recall and claims that it manipulated the blood plasma market by swallowing up competitors.

Investor Ellen Fischer filed the suit on behalf of Baxter in the Delaware Chancery Court, five months after a federal judge in Illinois refused to dismiss a putative shareholder class action that accuses the company's...
To view the full article, register now.